Live Breaking News & Updates on Inotek Pharmaceutical

Stay updated with breaking news from Inotek pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

[2021] Glaucoma Eye Drops Market 7.0% CAGR Find Out Growth Potential Through Demand Forecast 2027 |


Search jobs
29-Apr-2021
SEATTLE, April 29, 2021, (PHARMIWEB) Overview:
Glaucoma is a category of diseases marked by optic nerve injury, visual field loss, and secondary retinal ganglion cell damage, both of which can result in death.
Glaucoma is the world’s second leading cause of blindness and the leading cause of permanent blindness globally, according to the International Agency for the Prevention of Blindness. Primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG) are the two most common forms of glaucoma. The chance of developing glaucoma rises with age, increased intraocular pressure, a favorable family history of glaucoma, and ethnicity. ....

United States , Hong Kong , United Kingdom , Travatan Alcon , Asia Pacific , Lumigan Allergan , Valeant Pharmaceuticals International Inc , International Agency For The Prevention Of Blindness , Merck Co Inc , Pfizer Inc , Brightfocus Foundation , Senju Pharmaceutical Co Ltd , Cosopt Merck Co , Research Framework , Otsuka Pharmaceutical Co Ltd , World Health Organization Coronavirus Disease , Allergan Plc , National Center , Research Methodology , Drug Administration , Bausch Lomb Inc , American Academy Of Ophthalmology , View Press , Research Report Brochure , International Agency , Report Brochure ,